Direkt zum Seiteninhalt, zur Hauptnavigation, zur Unternavigation, zur Fußzeile.

28 April 2004

immatics biotechnologies increases first round of financing to EUR 8.25 million

EMBL Technology Fund (ETF), Heidelberg, joins the existing VC syndicate consisting of Wellington Partners, 3i Group, Grazia Equity, Merifin Capital and SEED/L-EA, and invests 0,5 million Euro into immatics biotechnologies GmbH from Tuebingen. The investment made by ETF increases the volume of the first financing round for immatics to a total of 8,25 million Euro.
Legal advice to the investors and the company was provided by Pöllath + Partners, Munich, and C’M’S’ Hasche-Sigle, Stuttgart.

-/ Press Release 2004-04-28 (PDF, 73 KB)

-/ Pressemitteilung 2004-04-28 (PDF, 75 KB)